Zofran

GlaxoSmithKline's Zofran Helps In Treatment Of Dehydration In Children

The drug Zofran, commonly given in children to limit vomiting can help in the recovery of children dehydrated by viral gastroenteritis //. A latest study released on Wednesday further highlights that emergency room doctors are overusing the drug. Childhood gastroenteritis accounts for over 1....

Strativa Pharmaceuticals Provides Product Pipeline Update

...ate pivotal studies comparing the bioequivalence of ondansetron ODFS 8mg to zofran ODT(R) 8mg was completed in December 2008 and supports the NDA filing of on... dose of ondansetron ODFS, taken with or without water, is bioequivalent to zofran ODT, taken under similar conditions. The antiemetic market totaled 4....

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

... The NDA is supported by positive data from completed pivotal studies in which ondansetron ODFS demonstrated bioequivalence against GlaxoSmithKline's zofran ODT(R) anti-emetic product. The ondansetron ODFS product has been developed as an anti-emetic therapy for the prevention of chemotherapy-induced nause...

MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

...rate that our PharmFilm(R) formulation is bioequivalent to the FDA approved zofran ODT(R) product in all human clinical trials. Looking ahead, we are now wor... thin film formulation of ondansetron was studied against GlaxoSmithKline's zofran ODT(R) product. About MonoSol Rx MonoSol Rx is a s...

Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis

...ith gastroenteritis. A meta-analysis (a statistical way to combine different studies) found that ondansetron, which is sold under the brand name zofran and is available as an intravenous infusion, tablet, disintegrating tablet or in liquid forms, reduced further vomiting after receipt in the emergency...

FDA Gives Preliminary Nod To Cipla And Sun Drugs

...used to prevent of nausea and vomiting following chemotherapy or radiation therapy for cancer. The drug is the generic equivalent of GlaxoSmithKline's zofran injection. ...

Zofran in Medical Technology

Strativa Pharmaceuticals Provides Product Pipeline Update

...ate pivotal studies comparing the bioequivalence of ondansetron ODFS 8mg to zofran ODT(R) 8mg was completed in December 2008 and supports the NDA filing of on... dose of ondansetron ODFS, taken with or without water, is bioequivalent to zofran ODT, taken under similar conditions. The antiemetic market totaled 4....

GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)

...uences of treatment, such as CINV, that many patients face. Building on our zofran heritage, casopitant represents our ongoing commitment to advancing cancer ...ential to add benefit beyond standard 5-HT3 inhibitors.(9) About Zofran zofran is a highly selective 5-HT3 receptor antagonist used for the prevention of ...

MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study

...used in the prevention and treatment of nausea and vomiting. MonoSol Rx's thin film formulation of ondansetron was studied against GlaxoSmithKline's zofran ODT(R) product. Based on the results of the study, MonoSol Rx is moving immediately to pivotal trials to enable drug submissions both in the US and Eu...

Zofran in Biological Technology

Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film

...film ondansetron formulation. Working with MonoSol Rx we were able to demonstrate that the thin film formulation is bioequivalent to the FDA approved zofran ODT(R) product in all human clinical trials." Anti-emetic therapies constitute one of the largest segments of the supportive care market in t...

New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting

...g in patients taking highly emetogenic chemotherapy. Preliminary data from clinical trials show that the addition of oral Rezonic to GlaxoSmithKline's zofran and Merck/Banyu's Decadron result in an 86 percent of patients with no emetic episodes and do not require rescue therapy compared with Emend's 68 perc...